No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
RAPT250117P1000
- 0.07
- +0.02+40.00%
15min DelayClose Jan 10 16:00 ET
0.07High0.07Low
0.07Open0.05Pre Close50 Volume10 Open Interest1.00Strike Price350.00Turnover309.82%IV29.55%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier6DDays to Expiry0.07Extrinsic Value100Contract SizeAmericanOptions Type-0.1893Delta0.4966Gamma18.86Leverage Ratio-0.0116Theta-0.0001Rho-3.57Eff Leverage0.0005Vega
Intraday
- 5D
- Daily
News
RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
RAPT Therapeutics Announces Leadership Changes and Realignment
Express News | RAPT Therapeutics Inc - William Rieflin Steps Down as Chair, Remains Consultant
Express News | RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company’s Board of Directors
Press Release: RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company's Board of Directors
Notable Analyst Calls This Week: FREYR Battery, Apple and ServiceNow Among Top Picks